FcγRIIIb and complement component C7 codeficiency in a patient with recurrence of fulminant meningococcal septic shock

Clinical Infectious Diseases

Volumn 40, Issue 11, 2005, Pages 1679-1683

  Debard, Anne Lise ^a   Lamy, Brigitte ^a   Monneret, Guillaume ^a   Mira, Jean Paul ^b   Pachot, Alexandre ^a   Kleijer, Marion ^e   Aillaud, Marie Françoise ^c   Boibieux, André ^d   Bienvenu, Jacques ^a   Carret, Gérard ^a   Fournier, Gérard ^a   Bohé, Julien ^a  

^a CENTRE HOSPITALIER LYON SUD   (France)

^b INSTITUT COCHIN   (France)

^c TIMONE HOSPITAL   (France)

^d CROIX ROUSSE HOSPITAL   (France)

^e ACADEMIC MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ANTITHROMBIN; CEFOTAXIME; CEFTRIAXONE; CELL SURFACE RECEPTOR; COMPLEMENT COMPONENT C7; FC RECEPTOR; HYDROCORTISONE; PROTEIN C; FCGR3B PROTEIN, HUMAN; LEUKOCYTE ANTIGEN;

ADOLESCENT; ADULT RESPIRATORY DISTRESS SYNDROME; ANAMNESIS; ARTICLE; ARTIFICIAL VENTILATION; BACTERIUM ISOLATION; CASE REPORT; CLINICAL FEATURE; COMPLEMENT DEFICIENCY; DISEASE SEVERITY; EPIDEMIC MENINGITIS; FEMALE; FINGER AMPUTATION; FLOW CYTOMETRY; FULMINANT MENINGOCOCCAL SEPTIC SHOCK; GENETIC ANALYSIS; GENOTYPE; HEART ARREST; HUMAN; INTENSIVE CARE; KIDNEY FAILURE; MENINGOCOCCOSIS; NEISSERIA MENINGITIDIS; NEUTROPHIL; PRIORITY JOURNAL; RASH; RECURRENT DISEASE; SEPTIC SHOCK; SKIN TRANSPLANTATION; BACTEREMIA; GENE EXPRESSION; GENETIC PREDISPOSITION; GENETICS; METABOLISM;

ADOLESCENT; ANTIGENS, CD; BACTEREMIA; COMPLEMENT C7; FEMALE; GENE EXPRESSION; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MENINGOCOCCAL INFECTIONS; NEUTROPHILS; RECEPTORS, IGG; RECURRENCE; SHOCK, SEPTIC;

EID: 21144454782     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/430065     Document Type: Article

References (16)

1. Figueroa JE, Densen P. Infectious diseases associated with complement deficiencies. Clin Microbiol Rev 1991; 4:359-95.
2. Bachelot C, Saffroy R, Gandrille S, Aiach M, Rendu F. Role of FcγRIIA gene polymorphism in human platelet activation by monoclonal antibodies. Thromb Haemost 1995; 74:1557-63.
3. de Haas M, Kleijer M, van Zwieten R, Roos D, von dem Borne AE. Neutrophil FcγRIIIb deficiency, nature, and clinical consequences: a study of 21 individuals from 14 families. Blood 1995; 86:2403-13.
4. Johnson VJ, Yucesoy B, Luster MI. Genotyping of single nucleotide polymorphisms in cytokine genes using real-time PCR allelic discrimination technology. Cytokine 2004; 27:135-41.
5. Emonts M, Hazelzet JA, de Groot R, Hermans PW. Host genetic determinants of Neisseria meningitidis infections. Lancet Infect Dis 2003; 3:565-77.
6. Balding J, Healy CM, Livingstone WJ, et al. Genomic polymorphic profiles in an Irish population with meningococcaemia: is it possible to predict severity and outcome of disease? Genes Immun 2003; 4:533-40.
7. Schluter B, Raufhake C, Erren M, et al. Effect of the interleukin-6 promoter polymorphism (-174 G/C) on the incidence and outcome of sepsis. Crit Care Med 2002; 30:32-7.
8. Arnaud E, Barbalat V, Nicaud V, et al. Polymorphisms in the 5′ regulatory region of the tissue factor gene and the risk of myocardial infarction and venous thromboembolism: the ECTIM and PATHROS studies. Etude Cas-Temoins de l'Infarctus du Myocarde. Paris Thrombosis Case-Control Study. Arterioscler Thromb Vasc Biol 2000; 20:892-8.
9. Bredius RG, Fijen CA, De Haas M, et al. Role of neutrophil FcγRIIa (CD32) and FcγRIIIb (CD16) polymorphic forms in phagocytosis of human IgG1- and IgG3-opsonized bacteria and erythrocytes. Immunology 1994; 83:624-30.
10. Fijen CA, Bredius RG, Kuijper EJ, et al. The role of Fcγ receptor polymorphisms and C3 in the immune defence against Neisseria meningitidis in complement-deficient individuals. Clin Exp Immunol 2000; 120:338-45.
11. Smith I, Vedeler C, Halstensen A. FcγRIIa and FcγRIIIb polymorphisms were not associated with meningococcal disease in Western Norway. Epidemiol Infect 2003; 130:193-9.
12. Platonov AE, Kuijper EJ, Vershinina IV, et al. Meningococcal disease and polymorphism of FcγRIIa (CD32) in late complement component-deficient individuals. Clin Exp Immunol 1998; 111:97-101.
13. Fossati G, Moots RJ, Bucknall RC, Edwards SW Differential role of neutrophil Fcγ receptor IIIB (CD16) in phagocytosis, bacterial killing, and responses to immune complexes. Arthritis Rheum 2002; 46:1351-61.
14. Fromont P, Bettaieb A, Skouri H, et al. Frequency of the polymorphonuclear neutrophil Fcγ receptor III deficiency in the French population and its involvement in the development of neonatal alloimmune neutropenia. Blood 1992; 79:2131-4.
15. Salmon JE, Millard SS, Brogle NL, Kimberly RP. Fcγ receptor IIIb enhances Fcγ receptor IIa function in an oxidant-dependent and allele-sensitive manner. J Clin Invest 1995; 95:2877-85.
16. Overturf GD. Indications for the immunological evaluation of patients with meningitis. Clin Infect Dis 2003; 36:189-94.